Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus

D. Giugliano, A. Ceriello, E. Razzoli, K. Esposito

Research output: Contribution to journalArticle


The role of postprandial hyperglycaemia in contributing to the risk of both micro- and macrovascular complications in patients with diabetes mellitus is being increasingly recognized. In type 2 diabetes, there is a progressive shift in the relative contributions of postprandial and fasting hyperglycaemia to the overall glycaemic control as the disease progresses. For patients with fairly good glycaemic control (glycosylated haemoglobin [HbA1c]

Original languageEnglish
Pages (from-to)199-210
Number of pages12
JournalClinical Drug Investigation
Issue number4
Publication statusPublished - 2008



  • Hyperglycaemia
  • Insulin lispro, therapeutic use
  • Insulin neutral protamine lispro/insulin lispro, therapeutic use
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this